The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by ...
Fusion Antibodies PLC 04 July 2024 4 July 2024 Fusion Antibodies plc ("Fusion" or the "Company") Trading update Fusion Antibodies plc...
Fusion Antibodies PLC 23 May 2024 23 May 2024 Fusion Antibodies plc ("Fusion" or the "Company") New contract with existing client Project...
Fusion Antibodies PLC 02 May 2024 Fusion Antibodies plc ("Fusion" or the "Company") Investor presentation ...
The following is a round-up of earnings and trading updates by London-listed companies, issued on Tuesday and not sep ...
Fusion Antibodies PLC 30 April 2024 The information contained within this announcement is deemed by the Company to constitute inside...
Fusion Antibodies PLC 16 April 2024 16 April 2024 Fusion Antibodies plc ("Fusion" or the "Company") Change of Auditor Fusion Antibodies...
Fusion Antibodies PLC on Monday said that it has signed a commercial contract to develop an OptiPhage library for a n ...
Fusion Antibodies PLC 15 April 2024 15 April 2024 Fusion Antibodies plc ("Fusion" or the "Company") Contract to develop a bespoke...
Fusion Antibodies PLC 02 April 2024 2 April 2024 Fusion Antibodies plc ("Fusion" or the "Company") Block admission six monthly return ...
Fusion Antibodies PLC 28 March 2024 28 March 2024 Fusion Antibodies plc ("Fusion" or the "Company") Total Voting Rights Fusion...
Fusion Antibodies PLC 11 March 2024 TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN GB00BDQZGK16 Issuer Name...
Fusion Antibodies PLC 08 March 2024 TR-1: Standard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.